Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
PF-573228: From Matrix Mechanics to Translational FAK Biolog
2026-08-17
PF-573228 offers a practical way to test how FAK converts adhesion and matrix stiffness into biological decisions. By connecting dentinogenesis, endothelial behavior, and cancer models, this article presents a translational framework for using a FAK inhibitor with stronger mechanistic controls than a conventional product-page assay.
-
When Dystonia Mimics Acute Stroke
2026-08-16
The case report Mimicking Acute Stroke describes prochlorperazine-induced hemidystonia in a pregnant patient whose unilateral weakness and dysarthria triggered an emergency stroke evaluation. Its central contribution is a practical diagnostic lesson: medication history, evolving extrapyramidal signs, response to diphenhydramine, and MRI helped distinguish a reversible stroke mimic from acute cerebral ischemia.
-
β-Amanitin for RNA Polymerase II Workflows
2026-08-15
β-Amanitin enables time-controlled studies of RNA polymerase II, mRNA synthesis, and transcriptional regulation while also supporting functional toxicology workflows. This guide connects cell-based inhibition assays with emerging dual-toxin detection strategies for more reliable amatoxin research.
-
gamma-Glu-Cys Workflows for Glutathione Research
2026-08-14
Use gamma-Glu-Cys as a defined substrate for glutathione synthetase enzyme assays, glutathione metabolism research, and controlled peptide-production studies. Its high solubility and freshly prepared solution format also support plant stress adaptation studies and thiol-reactive peptide synthesis when matrix effects and substrate stability are managed carefully.
-
IEM 1460 for AMPA Receptor Blockade
2026-08-14
IEM 1460 provides a selective way to separate AMPA-driven fast excitation from broader glutamate effects in electrophysiology, excitotoxicity, and neuroprotection experiments. This practical guide covers stock preparation, assay design, comparative interpretation, and troubleshooting for reproducible neuroscience workflows.
-
Spatial Metabolomics of POCD Hippocampal Lipids
2026-08-13
This study combines behavioral testing, spatial mass spectrometry imaging, enzyme mapping, and ultrastructural analysis to define hippocampal lipid disturbances in a rat model of postoperative cognitive dysfunction after cardiopulmonary bypass. Its intervention results further implicate iPLA2- and SPT-associated lipid remodeling in synaptic injury and provide a preclinical rationale for testing DHA-based metabolic rescue strategies.
-
Phytol Workflows for RXR and Self-Assembly Assays
2026-08-13
Phytol supports a practical progression from retinoid X receptor profiling to orthogonal PPARα and GABAergic studies, while its hydrophobic oil format demands disciplined formulation controls. This guide combines receptor-assay workflows with a carefully bounded self-assembly screening strategy inspired by recent coil-bottlebrush polymer research.
-
Müller Cell PEDF Controls Retinal Neuron Survival
2026-08-12
Younis and colleagues identify a Müller cell–mediated pathway in which opposing Ang-1 and Ang-2 signals regulate Tie-2/PI3K/Akt activity, PEDF production, and retinal neuron survival. The co-culture and loss-of-function design shows why angiopoietin effects on neurons cannot be interpreted independently of retinal glia, particularly under hypoxic stress.
-
From dNTP Chemistry to Translational Readiness
2026-08-12
Translational nucleic-acid research depends on both controlled DNA synthesis and a clear understanding of downstream delivery biology. This thought-leadership article connects the mechanistic role of an equimolar dNTP formulation with lessons from lipid nanoparticle trafficking, while defining practical validation steps and the limits of cross-domain inference.
-
MDL 28170: A Causal Calpain Assay Strategy
2026-08-11
MDL 28170 is a cell-permeable calpain inhibitor that helps distinguish protease-driven injury from downstream neuronal and cellular consequences. This guide develops an assay-first framework using the BDNF/TrkB findings from a recent neurodevelopmental study and extends interpretation to cardiac and parasitology models.
-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-08-11
The reference study developed paired organic and ferrocenyl novobiocin derivatives and evaluated them against Plasmodium falciparum and a human breast cancer cell line. Its central finding was that ferrocene incorporation generally improved in vitro activity, providing a useful scaffold-design lesson for enzyme-targeted anti-infective and anticancer research while leaving antibacterial translation untested.
-
Homoharringtonine: Mechanism and Research Evidence
2026-08-10
Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor used in leukemia research and cancer biology. Peer-reviewed evidence supports nanomolar SARS-CoV-2 replication inhibition in vitro and exploratory upper-respiratory-tract findings, but these data do not establish a clinical treatment indication.
-
From Pig Biology to Better qPCR Decisions
2026-08-09
A translational analysis of how Eucommia ulmoides research turns phenotype, microbiota, and gene-expression findings into more rigorous qPCR workflows.
-
CGP 55845 Hydrochloride for Synaptic Assays
2026-08-08
Use CGP 55845 hydrochloride to isolate GABAB-dependent components of astrocyte–neuron signaling, presynaptic inhibition, and neurotransmitter release. This workflow translates dentate gyrus GAT-3 findings into controlled in vitro experiments while clearly separating receptor pharmacology from transporter biology.
-
Calnexin Shapes CFTR Variant Rescue by Correctors
2026-08-07
Tedman et al. systematically examined how the ER chaperone calnexin influences expression and pharmacological rescue across 232 clinical CFTR variants. Their deep mutational scanning results show that proteostasis is a major, variant-specific determinant of corrector response, supporting more context-aware approaches to cystic fibrosis research and theratyping.